A six-month outbreak of penicillin-susceptible, exfoliative toxin A-producing Staphylococcus aureus ST15 affected 20 infants ...

An 18-month trial with 801,668 ICU admissions showed that mupirocin nasal ointment effectively reduces Staphylococcus aureus and MRSA infections by 18% and 15% respectively, offering hope in ICU ...

Preliminary results of a clinical trial indicate that starting patients on two IV antibiotics significantly reduces the ...

Preliminary SABEDTIO data from IDWeek 2026 show early dual IV therapy cut prolonged S aureus bacteremia to 6% from 16%, with ...

Staphylococcus aureus has been posing a significant global health threat, underscoring an urgent need for innovative preventive strategies, notably vaccines. This study presents an evaluation of a ...

Staphylococcus aureus (S. aureus) ranks among the globally most important causes of infections in humans and is considered a dreaded hospital pathogen. Active and passive immunization against ...

Invasive Staphylococcus aureus infections are common, causing high mortality, compounded by the propensity of the bacterium to develop drug resistance. S. aureusis an excellent case study of the ...

A 2026 review finds that Staphylococcus aureus PBP4 may offer a dual target for reversing noncanonical antibiotic resistance ...

A new study shows efficacy and safety of oral antibiotic therapy, in the form of pills, for Staphylococcus aureus bloodstream infections. Currently, infusions are the standard treatment. An ...

The skin bacterium Staphylococcus aureus often develops antibiotic resistance. It can then cause infections that are difficult to treat. Researchers at the University of Bonn have uncovered an ...